Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors

Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors

US Patent 10238649 · Granted Mar 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Masitinib for the treatment of sickle cell disease2025
Masitinib for the treatment of sickle cell disease2025
Compounds with anti-tumoral activity2020
Oxazole derivatives that inhibit Syk2019
Benzimidazole derivatives as selective proteine kinase inhibitors2019
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpo2018
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpo2018
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase in2018
Treatment of mastocytosis with masitinib2018
Treatment of mastocytosis with masitinib2018
Selective protein kinase inhibitors2015
Treatment of severe persistant asthma with masitinib2015